In over 70% of sporadic ccRCC cases, von Hippel–Lindau (VHL) tumor suppressor gene inactivation through sequence alteration, promoter CpG hypermethylation or loss of heterozygosity has been reported [3–5]. The gene discussed is VHL; the disease is neoplasm.